Inner Mongolia Furui Medical Science Co Ltd banner
I

Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049

Watchlist Manager
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
Watchlist
Price: 66.33 CNY 0.32% Market Closed
Market Cap: ¥17.6B

Net Margin

8.4%
Current
Declining
by 0.5%
vs 3-y average of 8.9%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
8.4%
=
Net Income
¥123.2m
/
Revenue
¥1.5B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
8.4%
=
Net Income
¥123.2m
/
Revenue
¥1.5B

Peer Comparison

Country Company Market Cap Net
Margin
CN
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
17.7B CNY
Loading...
US
Eli Lilly and Co
NYSE:LLY
997.2B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
CH
Roche Holding AG
SIX:ROG
281.1B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
303.5B USD
Loading...
CH
Novartis AG
SIX:NOVN
230.9B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.1B GBP
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.3T DKK
Loading...
US
Pfizer Inc
NYSE:PFE
154.7B USD
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...

Market Distribution

In line with most companies in China
Percentile
68th
Based on 8 721 companies
68th percentile
8.4%
Low
-416 945.9% — -1.5%
Typical Range
-1.5% — 8.9%
High
8.9% — 17 382.1%
Distribution Statistics
China
Min -416 945.9%
30th Percentile -1.5%
Median 3.5%
70th Percentile 8.9%
Max 17 382.1%

Inner Mongolia Furui Medical Science Co Ltd
Glance View

Market Cap
17.6B CNY
Industry
Pharmaceuticals

In the vast expanse of the healthcare landscape, Inner Mongolia Furui Medical Science Co., Ltd. has carved its niche by melding traditional Chinese medical wisdom with contemporary scientific advancements. Founded in the milieu of China's rich cultural heritage in Inner Mongolia, the company has emerged as a pivotal player in the pharmaceutical and biotechnology sectors. It specializes in the research, development, production, and sale of heparin products. Heparin, an anticoagulant drug crucial in preventing and treating blood clots, has been the cornerstone of Furui Medical's success, establishing them as a key supplier in both domestic and international markets. By leveraging China's comprehensive supply chain and stringent quality control measures, Furui has ensured its products meet the demanding standards of healthcare providers worldwide. At the heart of Furui Medical's business model is a well-oiled system that not only focuses on enhancing product efficacy but also strives for innovation in its production processes. The company has invested significantly in building state-of-the-art manufacturing facilities and a robust R&D department, which allow it to maintain a competitive edge in the biopharmaceutical domain. This focus on technological enhancement and adherence to international quality standards facilitates Furui Medical's penetration into global markets, particularly in Europe and North America. Additionally, their strategic partnerships and expansive distribution networks help them capitalize on emerging opportunities in the global anticoagulant market. Through this blend of tradition and modernity, Furui Medical not only contributes to the healing arts but also ensures sustainable business growth.

Intrinsic Value
38.49 CNY
Overvaluation 42%
Intrinsic Value
Price
I
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
8.4%
=
Net Income
¥123.2m
/
Revenue
¥1.5B
What is Inner Mongolia Furui Medical Science Co Ltd's current Net Margin?

The current Net Margin for Inner Mongolia Furui Medical Science Co Ltd is 8.4%, which is below its 3-year median of 8.9%.

How has Net Margin changed over time?

Over the last 3 years, Inner Mongolia Furui Medical Science Co Ltd’s Net Margin has decreased from 9.6% to 8.4%. During this period, it reached a low of 6.3% on Jun 30, 2025 and a high of 10.6% on Mar 31, 2024.

Back to Top